In early UK corporate news, GSK announced a buyback and upped its 2031 sales target. Here is what you need to know at the London market open: FTSE 100: called down 0.3% at 8,542.57 Hang Seng: down 1.0 ...

Pharmaceutical giant GSK has hiked its 2031 sales forecast to more than £40bn, up from £38bn, after reporting better than ...

The pharmaceutical giant targets an increase in core operating profit of between 6% and 8% in 2025, after cancer treatments ...

Pharmaceutical giant GlaxoSmithKline (GSK) has lifted its long-term sales guidance as it hailed a strong drug pipeline.

GSK today increased its 2031 sales outlook to more than £40 billion, up from £38 billion amid stronger progress in its ...

GSK Plc announced a share buyback of £2 billion as it saw better than expected profit in the fourth quarter. The share ...

Chinese stocks fell as they returned from a week-long holiday and have been volatile through the session. That volatility was exacerbated by news that the US Postal Service is to temporarily suspend ...

GSK forecast sales in 2025 to grow 3%-5% and reported better-than-expected fourth-quarter earnings, as strength in its HIV ...

FTSE 100 dips as trade tensions rattle markets; sterling gains. Entain jumps on BetMGM outlook, Vodafone slumps. US job data fuels rate cut bets. GSK, PMIs in focus.

On Monday, GSK plc (GSK) stock saw a decline, ending the day at $34.9 which represents a decrease of $-0.37 or -1.05% from the prior close of $35.27. The stock opened at $34.87 and touched a low of ...

GSK PLC closed 24.32% short of its 52-week high of £18.24, which the company achieved on May 16th.